|

Myc Inhibitor OMO-103 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: OMO 103, OMO-103, OMO103

Pipeline

Early 1: 1

Top Sponsors

  • OHSU Knight Cancer Institute1

Indications

  • Locally Advanced Pancreatic Ductal Adenocarcinoma1
  • Stage II Pancreatic Cancer AJCC v81
  • Stage IV Pancreatic Cancer AJCC v81
  • Stage III Pancreatic Cancer AJCC v81
  • Metastatic Pancreatic Ductal Adenocarcinoma1

Portland, Oregon1 trial

OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

OHSU Knight Cancer Institute

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.